Azenta (AZTA) | Stock Overview & Key Data
Azenta Performance Comparison
Stock Range
Today's Range
Low: $28.59
High: $29.34
on August 8, 2025
52 Week Range
Low: $23.91
High: $56.37
on May 7, 2025
on August 8, 2024
All-Time High: $124.79 on November 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.3B
EPS
-0.78
P/E Ratio (TTM)
-9.40
Forward P/E
69.12
P/B Ratio
0.79
PEG Ratio
69.12
Div. Yield
N/A
ROE
-9.15%
Beta
1.587
Debt to Equity
3.15
Financial Highlights
Profitability
Gross Margin
45.94%
Operating Margin
0.03%
Profit Margin
-16.68%
Returns and Earnings
Return on Assets (TTM)
-1.60%
Return on Equity (TTM)
-9.15%
EBITDA
$38.7M
Net Income (TTM)
$-167.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$14.68
Quarterly Revenue Growth (YoY)
-16.70%
Quarterly Earnings Growth (YoY)
-9.88%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Azenta AZTA | 1.33B Small-cap | -10.24% | -13.37% | 4.76% | -38.90% | -41.99% | -47.46% | -53.90% | -47.09% |
| Intuitive Surgical ISRG | 169.94B Large-cap | -2.70% | -10.85% | -12.65% | -21.09% | -10.30% | 1.43% | 97.21% | 106.02% |
| Becton, Dickinson BDX | 53.31B Large-cap | 9.71% | 10.81% | 15.21% | -15.70% | -14.57% | -17.97% | -26.61% | -23.17% |
| Lemaitre Vascular LMAT | 2.11B Mid-cap | 13.87% | 9.97% | 13.23% | -6.26% | 0.89% | 10.17% | 68.46% | 225.16% |
| Anbio Biotechnology NNNN | 1.87B Small-cap | 19.30% | 12.84% | 670.14% | 784.92% | 784.92% | 784.92% | 784.92% | 784.92% |
| AtriCure ATRC | 1.82B Small-cap | 2.62% | 11.63% | 13.25% | -15.97% | 16.15% | 68.91% | -32.05% | -12.16% |
Ownership & Short Interest
Insider Ownership
1.78%
Institutional Ownership
117.22%
Shares Short
5M
Short Ratio
4.65
Short % of Shares Outstanding
17.12%
Average 10-Day Volume
747K
Average 90-Day Volume
914K
Azenta Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Azenta would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AZTA's 52-week high and low?
- In the last 52 weeks, Azenta reached a high of $56.37 (on August 8, 2024) and a low of $23.91 (on May 7, 2025).
- What is the market cap and P/E ratio for AZTA?
- Curious about Azenta's size and valuation? Its market capitalization stands at 1.33B. When it comes to valuation, the P/E ratio (trailing twelve months) is -9.40, and the forward P/E (looking ahead) is 69.12.
- Does AZTA pay dividends? If so, what's the yield?
- As for dividends, Azenta isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Azenta's main competitors or similar companies to consider before investing?
When looking at Azenta, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG169.94B Healthcare Medical Instruments & Supplies 1.43% 97.21% Becton, Dickinson
BDX53.31B Healthcare Medical Instruments & Supplies -17.97% -26.61% Lemaitre Vascular
LMAT2.11B Healthcare Medical Instruments & Supplies 10.17% 68.46% Anbio Biotechnology
NNNN1.87B Healthcare Medical Instruments & Supplies 784.92% 784.92% AtriCure
ATRC1.82B Healthcare Medical Instruments & Supplies 68.91% -32.05% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Azenta Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Azenta's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -9.15%, the Debt to Equity ratio from the most recent quarter is 3.15, and its Gross Profit Margin stands at 45.94%.
- What is the recent revenue and earnings growth for AZTA?
- Looking at Azenta's growth, its revenue over the trailing twelve months (TTM) was $669M. Compared to the same quarter last year (YoY), quarterly revenue grew by -16.70%, and quarterly earnings saw a YoY growth of -9.88%.
- How much of AZTA stock is held by insiders and institutions?
- Wondering who owns Azenta stock? Company insiders (like executives and directors) hold about 1.78% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 117.22%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.